Press Release Source: Allos Therapeutics, Inc. On Thursday February 17, 2011, 9:00 am EST
WESTMINSTER, Colo.--(BUSINESS WIRE)-- Allos Therapeutics, Inc. (NASDAQ:ALTH - News), a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics, today announced that the Company will report its financial results for the fourth quarter and full year ended December 31, 2010 on Thursday, March 3, 2011, after the financial markets close. Following the release of the financial results, Allos management will provide a corporate update and review of the fourth quarter and full year 2010 results via audio webcast conference call on Thursday, March 3, 2011, at 4:30 p.m. Eastern Time (ET).
To access the live audio webcast or the subsequent archived recording, visit the “Investors - Presentations and Events” section of the Company’s website at www.allos.com. Alternatively, callers may participate in the conference call by dialing 1-800-762-8779 (U.S.) or +480-629-9771 (Canada and international). Participants should reference the Allos Therapeutics conference call. Webcast and telephone replays of the conference call will be available approximately two hours after the completion of the call through March 17, 2011. To access the replay, callers should dial 1-800-406-7325 (domestic) or +1-303-590-3030 (international) and use passcode 4410612#.
FEATURED Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • May 8, 2024 9:05 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • BLOZF • May 7, 2024 8:51 AM